Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Zeen Tong, Christian Atsriku, Usha Yerramilli, Xiaomin Wang, Yan Li, Josephine Reyes, Bin Fan, Hua Yang, Matthew Hoffmann & Sekhar Surapaneni. (2019) Absorption, distribution, metabolism and excretion of an isocitrate dehydrogenase-2 inhibitor enasidenib in rats and humans. Xenobiotica 49:2, pages 200-210.
Read now
Read now
Zeen Tong, Christian Atsriku, Usha Yerramilli, Xiaomin Wang, Jim Nissel, Yan Li & Sekhar Surapaneni. (2019) Absorption, distribution, metabolism, and excretion of mTOR kinase inhibitor CC-223 in rats, dogs, and humans. Xenobiotica 49:1, pages 43-53.
Read now
Read now
Valérie Mancel, François-Xavier Mathy, Pierre Boulanger, Stephen English, Marie Croft, Christopher Kenney, Tarra Knott, Armel Stockis & Massimo Bani. (2017) Pharmacokinetics and metabolism of [14C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers. Xenobiotica 47:8, pages 705-718.
Read now
Read now
C. M. Nijenhuis, J. H. M. Schellens & J. H. Beijnen. (2016) Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review. Drug Metabolism Reviews 48:2, pages 266-280.
Read now
Read now
Mario Pellegatti. (2014) The debate on animal ADME studies in drug development: an update. Expert Opinion on Drug Metabolism & Toxicology 10:12, pages 1615-1620.
Read now
Read now
Debra Luffer-Atlas. (2012) The early estimation of circulating drug metabolites in humans. Expert Opinion on Drug Metabolism & Toxicology 8:8, pages 985-997.
Read now
Read now
Angus N.R. Nedderman, Gordon J. Dear, Stephanie North, R. Scott Obach & David Higton. (2011) From definition to implementation: a cross-industry perspective of past, current and future MIST strategies. Xenobiotica 41:8, pages 605-622.
Read now
Read now
Hongbin Yu, Daniel Bischoff & Donald Tweedie. (2010) Challenges and solutions to metabolites in safety testing: impact of the International Conference on Harmonization M3(R2) guidance. Expert Opinion on Drug Metabolism & Toxicology 6:12, pages 1539-1549.
Read now
Read now
Graham Lappin & R Colin Garner. (2008) The utility of microdosing over the past 5 years. Expert Opinion on Drug Metabolism & Toxicology 4:12, pages 1499-1506.
Read now
Read now
Articles from other publishers (66)
Ganesh Moorthy, Gayle Pageau Pouliot, Lorraine Graham, Elizabeth Pilling, Lindsey Jung, Rachael Alcobi, Yali Zhu, Yan Li, Sharan Sidhu, Pablo Forte & Ganesh Mugundu. (2023) Comprehensive clinical pharmacology characterization of AZD4635 in healthy participants to support dosing considerations. British Journal of Clinical Pharmacology 89:9, pages 2775-2787.
Crossref
Crossref
Elliot DavenportDaniela E. NegruGeoff BadmanDavid M. Lindsay & William J. Kerr. (2023) Robust and General Late-Stage Methylation of Aryl Chlorides: Application to Isotopic Labeling of Drug-like Scaffolds. ACS Catalysis 13:17, pages 11541-11547.
Crossref
Crossref
R. Lock, P. J. H. Webborn, C. W. Vose & R. M. J. Ings. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
265
297
.
Yuxuan Ding, Simon S. Pedersen, Alex Lin, Ruoyu Qian & Zachary T. Ball. (2022) Direct formation and site-selective elaboration of methionine sulfoximine in polypeptides. Chemical Science 13:47, pages 14101-14105.
Crossref
Crossref
Ellen Cannady, Kishore Katyayan & Nita Patel. 2022. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
51
76
.
Sheila Annie Peters. 2021. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations
469
482
.
Mehr Fatima, Thomas Hausmaninger, Teemu Tomberg, Juho Karhu, Markku Vainio, Tuomas Hieta & Guillaume Genoud. (2021) Radiocarbon dioxide detection using cantilever-enhanced photoacoustic spectroscopy. Optics Letters 46:9, pages 2083.
Crossref
Crossref
Simon S. Pedersen, Aske S. Donslund, Jesper H. Mikkelsen, Oskar S. Bakholm, Florian Papp, Kim B. Jensen, Magnus B. F. Gustafsson & Troels Skrydstrup. (2021) A Nickel(II)‐Mediated Thiocarbonylation Strategy for Carbon Isotope Labeling of Aliphatic Carboxamides. Chemistry – A European Journal 27:24, pages 7114-7123.
Crossref
Crossref
Andrew McEwen. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
773
806
.
Sheila Annie Peters & Hugues Dolgos. (2019) Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them. Clinical Pharmacokinetics 58:11, pages 1355-1371.
Crossref
Crossref
Terry Podoll, Paul G. Pearson, Jerry Evarts, Tim Ingallinera, Elena Bibikova, Hao Sun, Mark Gohdes, Kristen Cardinal, Mitesh Sanghvi & J. Greg Slatter. (2019) Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. Drug Metabolism and Disposition 47:2, pages 145-154.
Crossref
Crossref
Dennis U. Nielsen, Karoline T. Neumann, Anders T. Lindhardt & Troels Skrydstrup. (2018)
Recent developments in carbonylation chemistry using [
13
C]CO, [
11
C]CO, and [
14
C]CO
. Journal of Labelled Compounds and Radiopharmaceuticals 61:13, pages 949-987.
Crossref
Crossref
Nicole A. Kratochwil, Stephen R. Dueker, Dieter Muri, Claudia Senn, HyeJin Yoon, Byung-Yong Yu, Gwan-Ho Lee, Feng Dong & Michael B. Otteneder. (2018) Nanotracing and cavity-ring down spectroscopy: A new ultrasensitive approach in large molecule drug disposition studies. PLOS ONE 13:10, pages e0205435.
Crossref
Crossref
Andrew McEwen. 2017. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
34
.
Gordon J. Dear & Andrew McEwen. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
45
85
.
T. Bohnert, A. Patel, I. Templeton, Y. Chen, C. Lu, G. Lai, L. Leung, S. Tse, H. J. Einolf, Y.-H. Wang, M. Sinz, R. Stearns, R. Walsky, W. Geng, S. Sudsakorn, D. Moore, L. He, J. Wahlstrom, J. Keirns, R. Narayanan, D. Lang & X. Yang. (2016) Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions--an Industry Perspective. Drug Metabolism and Disposition 44:8, pages 1399-1423.
Crossref
Crossref
Le Thuy Vuong, Qi Song, Hee Joo Lee, Ad F Roffel, Seok-Ho Shin, Young G Shin & Stephen R Dueker. (2016) Opportunities in low-level radiocarbon microtracing: applications and new technology. Future Science OA 2:1.
Crossref
Crossref
Graham Lappin. (2016) Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers. The Journal of Clinical Pharmacology 56:1, pages 11-23.
Crossref
Crossref
George S. Jackson, Jane A. Einstein, Tom Kubley, Berdine Martin, Connie M. Weaver & Marc Caffee. (2015) Biomedical graphite and CaF2 preparation and measurement at PRIME Lab. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 361, pages 358-362.
Crossref
Crossref
Susan Ebeler & Alyson Mitchell. 2015. Cosmeceuticals and Active Cosmetics, Third Edition. Cosmeceuticals and Active Cosmetics, Third Edition
411
428
.
Damayanthi Devineni, Joseph Murphy, Shean-Sheng Wang, Hans Stieltjes, Paul Rothenberg, Ellen Scheers & Rao N.V.S. Mamidi. (2015) Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants. Clinical Pharmacology in Drug Development 4:4, pages 295-304.
Crossref
Crossref
Graham Lappin. (2015) A historical perspective on radioisotopic tracers in metabolism and biochemistry. Bioanalysis 7:5, pages 531-540.
Crossref
Crossref
Charles S. Elmore & Ryan A. Bragg. (2015) Isotope chemistry; a useful tool in the drug discovery arsenal. Bioorganic & Medicinal Chemistry Letters 25:2, pages 167-171.
Crossref
Crossref
Susanna Tse, Louis Leung, Sangeeta Raje, Mark Seymour, Yoko Shishikura & R. Scott Obach. (2014)
Disposition and Metabolic Profiling of [
14
C]Cerlapirdine Using Accelerator Mass Spectrometry
. Drug Metabolism and Disposition 42:12, pages 2023-2032.
Crossref
Crossref
Claire Beaumont, Graeme C. Young, Tom Cavalier & Malcolm A. Young. (2014) Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches. British Journal of Clinical Pharmacology 78:6, pages 1185-1200.
Crossref
Crossref
Gérard Hopfgartner. 2013. Mass Spectrometry for Drug Discovery and Drug Development. Mass Spectrometry for Drug Discovery and Drug Development
1
35
.
Ethan Hoffmann, Jeff Wald, Siva Lavu, John Roberts, Claire Beaumont, Jon Haddad, Peter Elliott, Christoph Westphal & Eric Jacobson. (2013) Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. British Journal of Clinical Pharmacology 75:1, pages 186-196.
Crossref
Crossref
Fuyuki Tokanai, Kazuhiro Kato, Minoru Anshita, Hirohisa Sakurai, Akihiro Izumi, Teiko Toyoguchi, Takeshi Kobayashi, Hiroko Miyahara, Motonari Ohyama & Yasuharu Hoshino. (2016) Present Status of YU-AMS System. Radiocarbon 55:2, pages 251-259.
Crossref
Crossref
Angela Dudda & Gert Ulrich Kuerzel. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1053
1094
.
Hao Jiang, Jianing Zeng, Wenying Li, Marc Bifano, Huidong Gu, Craig Titsch, John Easter, Richard Burrell, Hamza Kandoussi, Anne-Françoise Aubry & Mark E. Arnold. (2012) Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay. Analytical Chemistry 84:22, pages 10031-10037.
Crossref
Crossref
Richard A. Graham, Cornelis E. C. A. Hop, Marie T. Borin, Bert L. Lum, Dawn Colburn, Ilsung Chang, Young G. Shin, Vikram Malhi, Jennifer A. Low & Mark J. Dresser. (2012) Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects. British Journal of Clinical Pharmacology 74:5, pages 788-796.
Crossref
Crossref
Jean-Pierre Delord, Jaafar Bennouna, Loïc Mourey, Joël Bougaret, Maud Brandely-Talbot & Pierre Ferré. (2012) Vinflunine Oral Pharmacokinetics and Absolute Bioavailability of Soft and Hard Gelatin Capsules. Clinical Pharmacokinetics 51:6, pages 357-364.
Crossref
Crossref
Xiaomin Wang, Voon Ong & Mark Seymour. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
331
338
.
Natalia Penner, Lin Xu & Chandra Prakash. (2012) Radiolabeled Absorption, Distribution, Metabolism, and Excretion Studies in Drug Development: Why, When, and How?. Chemical Research in Toxicology 25:3, pages 513-531.
Crossref
Crossref
Alexander V. LyubimovShelby Anderson, Debra Luffer‐Atlas & Mary Pat Knadler. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
27
.
Alexander V. LyubimovBenny M. Amore. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
39
.
Sergei F. Boulyga. (2011) Mass spectrometric analysis of long-lived radionuclides in bio-assays. International Journal of Mass Spectrometry 307:1-3, pages 200-210.
Crossref
Crossref
Stephen R. Dueker, Le T. Vuong, Peter N. Lohstroh, Jason A. Giacomo & John S. Vogel. (2011) Quantifying exploratory low dose compounds in humans with AMS. Advanced Drug Delivery Reviews 63:7, pages 518-531.
Crossref
Crossref
Claudia C. Wagner & Oliver Langer. (2011) Approaches using molecular imaging technology — use of PET in clinical microdose studies. Advanced Drug Delivery Reviews 63:7, pages 539-546.
Crossref
Crossref
John S. Vogel, Peter Lohstroh, Brad Keck & Stephen R. Dueker. 2011. Mass Spectrometry in Drug Metabolism and Disposition. Mass Spectrometry in Drug Metabolism and Disposition
525
566
.
Graham Lappin, Mark Seymour, Graeme Young, David Higton & Howard M Hill. (2011) AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration. Bioanalysis 3:4, pages 393-405.
Crossref
Crossref
Claudia C. Wagner, Marie Simpson, Markus Zeitlinger, Martin Bauer, Rudolf Karch, Aiman Abrahim, Thomas Feurstein, Matthias Schütz, Kurt Kletter, Markus Müller, Graham Lappin & Oliver Langer. (2011) A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil. Clinical Pharmacokinetics 50:2, pages 111-120.
Crossref
Crossref
Gordon J Dear, Claire Beaumont, Andrew Roberts, Bianca Squillaci, Steve Thomas, Mike Nash & Donna Fraser. (2011) Approaches for the rapid identification of drug metabolites in early clinical studies. Bioanalysis 3:2, pages 197-213.
Crossref
Crossref
Thomas A. Baillie & Allan E. Rettie. (2011) Role of Biotransformation in Drug-Induced Toxicity: Influence of Intra- and Inter-Species Differences in Drug Metabolism. Drug Metabolism and Pharmacokinetics 26:1, pages 15-29.
Crossref
Crossref
Tim Schulze-König, Lukas Wacker & Hans-Arno Synal. (2011) Direct radiocarbon analysis of exhaled air. J. Anal. At. Spectrom. 26:2, pages 287-292.
Crossref
Crossref
Ulrich Kuerzel, Volker Krone, Manfred Zimmer & Gareth Shackleton. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
73
103
.
Angus N. R. Nedderman & Don K. Walker. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
131
143
.
Graham Lappin. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
115
130
.
Z Tozuka, H Kusuhara, K Nozawa, Y Hamabe, I Ikushima, T Ikeda & Y Sugiyama. (2010) Microdose Study of 14C-Acetaminophen With Accelerator Mass Spectrometry to Examine Pharmacokinetics of Parent Drug and Metabolites in Healthy Subjects. Clinical Pharmacology & Therapeutics 88:6, pages 824-830.
Crossref
Crossref
J. Greg Slatter. 2010. Biotransformation and Metabolite Elucidation of Xenobiotics. Biotransformation and Metabolite Elucidation of Xenobiotics
295
312
.
Stephen H. Curry & Robin Whelpton. 2010. Drug Disposition and Pharmacokinetics. Drug Disposition and Pharmacokinetics
269
278
.
Angus NR Nedderman & Pat Wright. (2010) Looking back through the MIST: a perspective of evolving strategies and key focus areas for metabolite safety analysis. Bioanalysis 2:7, pages 1235-1248.
Crossref
Crossref
Shelby Anderson, Mary Pat Knadler & Debra Luffer-Atlas. (2010) Overview of metabolite safety testing from an industry perspective. Bioanalysis 2:7, pages 1249-1261.
Crossref
Crossref
Stephen R DuekerPeter N LohstrohJason A GiacomoLe T VuongBradly D KeckJohn S Vogel. (2010) Early human ADME using microdoses and microtracers: bioanalytical considerations. Bioanalysis 2:3, pages 441-454.
Crossref
Crossref
Paul T HendersonChong-xian Pan. (2010) Human microdosing for the prediction of patient response. Bioanalysis 2:3, pages 373-376.
Crossref
Crossref
John S VogelJason A Giacomo, Tim Schulze-KönigBradly D Keck, Peter Lohstroh & Stephen Dueker. (2010)
Accelerator mass spectrometry best practices for accuracy and precision in bioanalytical
14
C measurements
. Bioanalysis 2:3, pages 455-468.
Crossref
Crossref
Ali Arjomand. (2010) Accelerator mass spectrometry-enabled studies: current status and future prospects. Bioanalysis 2:3, pages 519-541.
Crossref
Crossref
Kin Y. TamAlex Avdeef, Oksana Tsinman & Na Sun. (2009) The Permeation of Amphoteric Drugs through Artificial Membranes − An in Combo Absorption Model Based on Paracellular and Transmembrane Permeability. Journal of Medicinal Chemistry 53:1, pages 392-401.
Crossref
Crossref
Graham Lappin. 2010. Clinical Pharmacology: Current Topics and Case Studies. Clinical Pharmacology: Current Topics and Case Studies
157
166
.
Paul de KoningJames Keirns. (2009) Clinical pharmacology, biomarkers and personalized medicine: education please. Biomarkers in Medicine 3:6, pages 685-700.
Crossref
Crossref
Gerhard GrossIan Wilson. (2009) Issues in the safety testing of metabolites. Future Medicinal Chemistry 1:8, pages 1381-1390.
Crossref
Crossref
Laurent Leclercq, Filip Cuyckens, Geert S. J. Mannens, Ronald de Vries, Philip Timmerman & David C. Evans. (2009) Which Human Metabolites Have We MIST? Retrospective Analysis, Practical Aspects, and Perspectives For Metabolite Identification and Quantification in Pharmaceutical Development. Chemical Research in Toxicology 22:2, pages 280-293.
Crossref
Crossref
Shelby Anderson, Debra Luffer-Atlas & Mary Pat Knadler. (2009) Predicting Circulating Human Metabolites: How Good Are We?. Chemical Research in Toxicology 22:2, pages 243-256.
Crossref
Crossref
E. Hywel Evans, Jason A. Day, Christopher D. Palmer & Clare M. M. Smith. (2009) Atomic Spectrometry Update. Advances in atomic spectrometry and related techniques. Journal of Analytical Atomic Spectrometry 24:6, pages 711.
Crossref
Crossref
Andrew Taylor, Simon Branch, Martin P. Day, Marina Patriarca & Mark White. (2009) Atomic Spectrometry Update. Clinical and biological materials, foods and beverages. Journal of Analytical Atomic Spectrometry 24:4, pages 535.
Crossref
Crossref
Thomas N. Thompson. 2009. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry Volume 44
459
474
.